Digitalisation of health records leveraging RWE

  • “It’s getting more expensive to do traditional clinical trial research, so industry is looking at ways it can achieve similar goals using routinely collected data,” said Paul Taylor, a health informatics expert at University College London.
  • “As the breadth and reliability of RWE increases, so do opportunities for FDA to also make use of this information,” U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb

Click here to see the source article


Hirschler, B. (2018, March 01). Big pharma, big data – why drugmakers want your health records. Retrieved from


About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit and contact us at

Posted in Blogs.